164 related articles for article (PubMed ID: 35759195)
1. Assaying RIPK2 Activation by Complex Formation.
Steinle H; Ellwanger K; Kufer TA
Methods Mol Biol; 2022; 2523():133-150. PubMed ID: 35759195
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3 and erlin proteins differentially interact with RIPK2 complexes.
Steinle H; Ellwanger K; Mirza N; Briese S; Kienes I; Pfannstiel J; Kufer TA
J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34152391
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Localization of NLRs upon Shigella flexneri Infection Exemplified by NOD1.
Arnold C; Ellwanger K; Kufer TA
Methods Mol Biol; 2022; 2421():37-56. PubMed ID: 34870810
[TBL] [Abstract][Full Text] [Related]
4. XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures.
Ellwanger K; Briese S; Arnold C; Kienes I; Heim V; Nachbur U; Kufer TA
Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31350258
[TBL] [Abstract][Full Text] [Related]
5. Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.
Rivoal M; Dubuquoy L; Millet R; Leleu-Chavain N
J Med Chem; 2023 Nov; 66(21):14391-14410. PubMed ID: 37857324
[TBL] [Abstract][Full Text] [Related]
6. Selective autophagy of RIPosomes maintains innate immune homeostasis during bacterial infection.
Mehto S; Jena KK; Yadav R; Priyadarsini S; Samal P; Krishna S; Dhar K; Jain A; Chauhan NR; Murmu KC; Bal R; Sahu R; Jaiswal P; Sahoo BS; Patnaik S; Kufer TA; Rusten TE; Chauhan S; Prasad P; Chauhan S
EMBO J; 2022 Dec; 41(23):e111289. PubMed ID: 36221902
[TBL] [Abstract][Full Text] [Related]
7. RIPosomes are targets of IRGM-SQSTM1-dependent autophagy.
Mehto S; Kundu S; Chauhan S; Chauhan S
Autophagy; 2023 Mar; 19(3):1045-1047. PubMed ID: 36628446
[TBL] [Abstract][Full Text] [Related]
8. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.
Nachbur U; Stafford CA; Bankovacki A; Zhan Y; Lindqvist LM; Fiil BK; Khakham Y; Ko HJ; Sandow JJ; Falk H; Holien JK; Chau D; Hildebrand J; Vince JE; Sharp PP; Webb AI; Jackman KA; Mühlen S; Kennedy CL; Lowes KN; Murphy JM; Gyrd-Hansen M; Parker MW; Hartland EL; Lew AM; Huang DC; Lessene G; Silke J
Nat Commun; 2015 Mar; 6():6442. PubMed ID: 25778803
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of RIP2 activation and signaling.
Gong Q; Long Z; Zhong FL; Teo DET; Jin Y; Yin Z; Boo ZZ; Zhang Y; Zhang J; Yang R; Bhushan S; Reversade B; Li Z; Wu B
Nat Commun; 2018 Nov; 9(1):4993. PubMed ID: 30478312
[TBL] [Abstract][Full Text] [Related]
10. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
[TBL] [Abstract][Full Text] [Related]
11. Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.
Zhang W; Wang Y
Histochem Cell Biol; 2022 Feb; 157(2):173-182. PubMed ID: 34825931
[TBL] [Abstract][Full Text] [Related]
12. Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells.
Park JY; Lee TS; Noh EJ; Jang AR; Ahn JH; Kim DY; Jung DH; Song EJ; Lee YJ; Lee YJ; Lee SK; Park JH
Am J Reprod Immunol; 2021 Jul; 86(1):e13403. PubMed ID: 33580557
[TBL] [Abstract][Full Text] [Related]
13. RIPK2: a promising target for cancer treatment.
You J; Wang Y; Chen H; Jin F
Front Pharmacol; 2023; 14():1192970. PubMed ID: 37324457
[TBL] [Abstract][Full Text] [Related]
14. NLRC3-like 1 inhibits NOD1-RIPK2 pathway via targeting RIPK2.
Fang H; Wu XM; Hu YW; Song YJ; Zhang J; Chang MX
Dev Comp Immunol; 2020 Nov; 112():103769. PubMed ID: 32634524
[TBL] [Abstract][Full Text] [Related]
15. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
16. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases.
Pham AT; Ghilardi AF; Sun L
Front Pharmacol; 2023; 14():1127722. PubMed ID: 36959850
[TBL] [Abstract][Full Text] [Related]
18. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional insights into CARDs of zebrafish (Danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2.
Maharana J; Dehury B; Sahoo JR; Jena I; Bej A; Panda D; Sahoo BR; Patra MC; Pradhan SK
Mol Biosyst; 2015 Aug; 11(8):2324-36. PubMed ID: 26079944
[TBL] [Abstract][Full Text] [Related]
20. XIAP mediates NOD signaling via interaction with RIP2.
Krieg A; Correa RG; Garrison JB; Le Negrate G; Welsh K; Huang Z; Knoefel WT; Reed JC
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14524-9. PubMed ID: 19667203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
